{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:41:04Z","timestamp":1781880064947,"version":"3.54.5"},"reference-count":54,"publisher":"Impact Journals, LLC","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,3,22]]},"DOI":"10.18632\/oncotarget.7320","type":"journal-article","created":{"date-parts":[[2016,2,17]],"date-time":"2016-02-17T19:12:46Z","timestamp":1455736366000},"page":"14350-14365","source":"Crossref","is-referenced-by-count":26,"title":["Hedgehog inhibitors selectively target cell migration and adhesion of mantle cell lymphoma in bone marrow microenvironment"],"prefix":"10.18632","volume":"7","author":[{"given":"Han","family":"Zhang","sequence":"first","affiliation":[{"name":"Center for Stem Cell and Regenerative Disease, Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases (IMM), The University of Texas-Health Science Center at Houston, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Chen","sequence":"additional","affiliation":[{"name":"Center for Stem Cell and Regenerative Disease, Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases (IMM), The University of Texas-Health Science Center at Houston, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sattva S.","family":"Neelapu","sequence":"additional","affiliation":[{"name":"Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Romaguera","sequence":"additional","affiliation":[{"name":"Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nami","family":"McCarty","sequence":"additional","affiliation":[{"name":"Center for Stem Cell and Regenerative Disease, Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases (IMM), The University of Texas-Health Science Center at Houston, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,2,11]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1182\/blood-2014-05-521898","article-title":"Mantle cell lymphoma: evolving management strategies","volume":"125","author":"Rule","year":"2015","journal-title":"Blood"},{"key":"2","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1158\/1535-7163.MCT-07-2118","article-title":"Targeting of sonic hedgehog-GLI signaling: a potential strategy to improve therapy for mantle cell lymphoma","volume":"7","author":"Joshi","year":"2008","journal-title":"Molecular cancer therapeutics"},{"key":"3","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/leu.2010.35","article-title":"Hedgehog signaling pathway is activated in diffuse large B-cell lymphoma and contributes to tumor cell survival and proliferation","volume":"24","author":"Vega","year":"2010","journal-title":"Leukemia"},{"key":"4","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1182\/blood-2014-03-557298","article-title":"A critical role of autocrine sonic hedgehog signaling in human CD138+ myeloma cell survival and drug resistance","volume":"124","author":"Yi","year":"2014","journal-title":"Blood"},{"key":"5","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrc796","article-title":"Gli and hedgehog in cancer: tumours, embryos and stem cells","volume":"2","author":"Dahmane","year":"2002","journal-title":"Nature reviews Cancer"},{"key":"6","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1006\/mcne.2001.1026","article-title":"Sonic hedgehog is required during an early phase of oligodendrocyte development in mammalian brain","volume":"18","author":"Rowitch","year":"2001","journal-title":"Molecular and cellular neurosciences"},{"key":"7","doi-asserted-by":"crossref","first-page":"e27306","DOI":"10.1371\/journal.pone.0027306","article-title":"Hedgehog signaling antagonist GDC-0449 (Vismodegib) inhibits pancreatic cancer stem cell characteristics: molecular mechanisms","volume":"6","author":"Shankar","year":"2011","journal-title":"PloS one"},{"key":"8","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1158\/1078-0432.CCR-14-1234","article-title":"Phase I Dose-Escalation Trial of the Oral Investigational Hedgehog Signaling Pathway Inhibitor TAK-441 in Patients with Advanced Solid Tumors","volume":"21","author":"Bowles","year":"2015","journal-title":"Clinical cancer research"},{"key":"9","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1056\/NEJMoa0905360","article-title":"Inhibition of the hedgehog pathway in advanced basal-cell carcinoma","volume":"361","author":"Low","year":"2009","journal-title":"The New England journal of medicine"},{"key":"10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.canlet.2012.02.035","article-title":"SDF-1\/CXCR4 signaling induces pancreatic cancer cell invasion and epithelial-mesenchymal transition in vitro through non-canonical activation of Hedgehog pathway","volume":"322","author":"Wang","year":"2012","journal-title":"Cancer letters"},{"key":"11","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1158\/0008-5472.CAN-11-2681","article-title":"Hedgehog signaling inhibition blocks growth of resistant tumors through effects on tumor microenvironment","volume":"72","author":"Weilbaecher","year":"2012","journal-title":"Cancer research"},{"key":"12","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1158\/1078-0432.CCR-10-2745","article-title":"Phase I trial of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with refractory, locally advanced or metastatic solid tumors","volume":"17","author":"Von Hoff","year":"2011","journal-title":"Clinical cancer research"},{"key":"13","first-page":"1","article-title":"Phase II evaluation of IPI-926, an oral Hedgehog inhibitor, in patients with myelofibrosis","author":"Verstovsek","year":"2015","journal-title":"Leukemia & lymphoma"},{"key":"14","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1158\/1535-7163.MCT-13-0731","article-title":"Hedgehog pathway inhibition in chondrosarcoma using the smoothened inhibitor IPI-926 directly inhibits sarcoma cell growth","volume":"13","author":"Wunder","year":"2014","journal-title":"Molecular cancer therapeutics"},{"key":"15","doi-asserted-by":"crossref","first-page":"e88386","DOI":"10.1371\/journal.pone.0088386","article-title":"Down-regulation of Gli transcription factor leads to the inhibition of migration and invasion of ovarian cancer cells via integrin beta4-mediated FAK signaling","volume":"9","author":"Luo","year":"2014","journal-title":"PloS one"},{"key":"16","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/neuonc\/not011","article-title":"NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by regulating miR-21, miR-128, and miR-200","volume":"15","author":"Shankar","year":"2013","journal-title":"Neuro-oncology"},{"key":"17","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1038\/bjc.2014.421","article-title":"Inhibition of Hedgehog signalling by NVP-LDE225 (Erismodegib) interferes with growth and invasion of human renal cell carcinoma cells","volume":"111","author":"Bianco","year":"2014","journal-title":"British journal of cancer"},{"key":"18","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1158\/1078-0432.CCR-13-1710","article-title":"A phase I, multicenter, open-label, first-in-human, dose-escalation study of the oral smoothened inhibitor Sonidegib (LDE225) in patients with advanced solid tumors","volume":"20","author":"Dummer","year":"2014","journal-title":"Clinical cancer research"},{"key":"19","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.ctrv.2014.02.003","article-title":"Crosstalk between hedgehog and other signaling pathways as a basis for combination therapies in cancer","volume":"40","author":"Adjei","year":"2014","journal-title":"Cancer treatment reviews"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.140","article-title":"Differential PAX5 levels promote malignant B cell, infiltration, progression and drug resistance and, predict a poor prognosis in MCL patients independent, of CCND1","author":"McCarty","year":"2015","journal-title":"Leukemia"},{"key":"21","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.semcancer.2011.09.006","article-title":"The microenvironment in mantle cell lymphoma: cellular and molecular pathways and emerging targeted therapies","volume":"21","author":"Ford","year":"2011","journal-title":"Seminars in cancer biology"},{"key":"22","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1182\/blood-2008-10-185827","article-title":"Mantle cell lymphoma cells express high levels of CXCR4, CXCR5, and VLA-4 (CD49d): importance for interactions with the stromal microenvironment and specific targeting","volume":"113","author":"Burger","year":"2009","journal-title":"Blood"},{"key":"23","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1182\/blood-2003-09-3103","article-title":"Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas","volume":"104","author":"Semenzato","year":"2004","journal-title":"Blood"},{"key":"24","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/sj.leu.2402107","article-title":"Differential expression of chemokine receptors in B cell malignancies","volume":"15","author":"Duhrsen","year":"2001","journal-title":"Leukemia"},{"key":"25","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1158\/1078-0432.CCR-1182-3","article-title":"CCL19 and CXCL12 trigger in vitro chemotaxis of human mantle cell lymphoma B cells","volume":"10","author":"Pistoia","year":"2004","journal-title":"Clinical cancer research"},{"key":"26","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1200\/JCO.1999.17.6.1869","article-title":"Expression of beta-integrin adhesion molecules in non-Hodgkin's lymphoma: correlation with clinical and evolutive features","volume":"17","author":"Montserrat","year":"1999","journal-title":"Journal of clinical oncology"},{"key":"27","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1182\/blood-2007-12-130179","article-title":"Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4\/SDF-1 interaction","volume":"112","author":"Dipersio","year":"2008","journal-title":"Blood"},{"key":"28","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.1182\/blood-2007-10-120329","article-title":"The monoclonal anti-VLA-4 antibody natalizumab mobilizes CD34+ hematopoietic progenitor cells in humans","volume":"111","author":"Haas","year":"2008","journal-title":"Blood"},{"key":"29","first-page":"47","article-title":"Hedgehog pathway as a drug target: Smoothened inhibitors in development","volume":"5","author":"Matsui","year":"2012","journal-title":"OncoTargets and therapy"},{"key":"30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/jmcb\/mjs010","article-title":"Imatinib triggers mesenchymal-like conversion of CML cells associated with increased aggressiveness","volume":"4","author":"Luciano","year":"2012","journal-title":"Journal of molecular cell biology"},{"key":"31","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1124\/mol.107.040105","article-title":"Effects of active and inactive phospholipase D2 on signal transduction, adhesion, migration, invasion, and metastasis in EL4 lymphoma cells","volume":"74","author":"Meier","year":"2008","journal-title":"Molecular pharmacology"},{"key":"32","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1055\/s-0035-1544229","article-title":"Latent Heparanase Facilitates VLA-4-Mediated Melanoma Cell Binding and Emerges As a Relevant Target of Heparin in the Interference with Metastatic Progression","volume":"41","author":"Bendas","year":"2015","journal-title":"Seminars in thrombosis and hemostasis"},{"key":"33","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1006\/cimm.1996.0188","article-title":"Focal adhesion kinase-related fakB is regulated by the integrin LFA-1 and interacts with the SH3 domain of phospholipase C gamma 1","volume":"171","author":"Kanner","year":"1996","journal-title":"Cellular immunology"},{"key":"34","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1182\/blood-2002-03-0844","article-title":"Gene expression profiling of the functionally distinct human bone marrow stromal cell lines HS-5 and HS-27a","volume":"100","author":"Torok-Storb","year":"2002","journal-title":"Blood"},{"key":"35","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1089\/adt.2008.0187","article-title":"A human CXCL13-induced actin polymerization assay measured by fluorescence plate reader","volume":"8","author":"Miao","year":"2010","journal-title":"Assay and drug development technologies"},{"key":"36","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1089\/scd.2010.0263","article-title":"Stromal-derived factor-1\/CXCR4 signaling: indispensable role in homing and engraftment of hematopoietic stem cells in bone marrow","volume":"20","author":"Gangenahalli","year":"2011","journal-title":"Stem cells and development"},{"key":"37","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1158\/1078-0432.CCR-15-0987","article-title":"ROS induced CXCR4 signaling regulates mantle cell lymphoma (MCL) cell survival and drug resistance in the bone marrow microenvironment via autophagy","volume":"22","author":"McCarty","year":"2016","journal-title":"Clinical cancer research"},{"key":"38","doi-asserted-by":"crossref","first-page":"e69126","DOI":"10.1371\/journal.pone.0069126","article-title":"Nuclear translocation of B-cell-specific transcription factor, BACH2, modulates ROS mediated cytotoxic responses in mantle cell lymphoma","volume":"8","author":"McCarty","year":"2013","journal-title":"PloS one"},{"key":"39","first-page":"8","article-title":"ROS-mediated regulation of CXCR4 in cancer","author":"Hinton","year":"2013","journal-title":"Frontiers in biology"},{"key":"40","doi-asserted-by":"crossref","first-page":"5278","DOI":"10.1158\/1078-0432.CCR-12-0351","article-title":"Counteracting autophagy overcomes resistance to everolimus in mantle cell lymphoma","volume":"18","author":"Roue","year":"2012","journal-title":"Clinical cancer research"},{"key":"41","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cell.2010.01.028","article-title":"Methods in mammalian autophagy research","volume":"140","author":"Levine","year":"2010","journal-title":"Cell"},{"key":"42","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/nature04872","article-title":"New signals from the invasive front","volume":"441","author":"Christofori","year":"2006","journal-title":"Nature"},{"key":"43","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1126\/science.1203543","article-title":"A perspective on cancer cell metastasis","volume":"331","author":"Weinberg","year":"2011","journal-title":"Science"},{"key":"44","doi-asserted-by":"crossref","first-page":"5002","DOI":"10.1182\/blood-2011-07-368142","article-title":"Canonical and noncanonical Hedgehog pathway in the pathogenesis of multiple myeloma","volume":"120","author":"Anderson","year":"2012","journal-title":"Blood"},{"key":"45","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ceb.2006.08.011","article-title":"Integrin-regulated FAK-Src signaling in normal and cancer cells","volume":"18","author":"Schlaepfer","year":"2006","journal-title":"Current opinion in cell biology"},{"key":"46","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0165-2478(96)02671-5","article-title":"Where the outside meets the inside: integrins as activators and targets of signal transduction cascades","volume":"54","author":"Hogg","year":"1996","journal-title":"Immunology letters"},{"key":"47","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1084\/jem.20021477","article-title":"Sustained activation of cell adhesion is a differentially regulated process in B lymphopoiesis","volume":"197","author":"Silberstein","year":"2003","journal-title":"The Journal of experimental medicine"},{"key":"48","doi-asserted-by":"crossref","first-page":"e76785","DOI":"10.1371\/journal.pone.0076785","article-title":"Sonic hedgehog regulates osteoblast function by focal adhesion kinase signaling in the process of fracture healing","volume":"8","author":"Sasaki","year":"2013","journal-title":"PloS one"},{"key":"49","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/carcin\/bgs274","article-title":"Sonic hedgehog signaling pathway induces cell migration and invasion through focal adhesion kinase\/AKT signaling-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9 in liver cancer","volume":"34","author":"Cheng","year":"2013","journal-title":"Carcinogenesis"},{"key":"50","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.canlet.2015.01.032","article-title":"Membrane microvesicles as mediators for melanoma-fibroblasts communication: Roles of the VCAM-1\/VLA-4 axis and the ERK1\/2 signal pathway","volume":"360","author":"Shang","year":"2015","journal-title":"Cancer letters"},{"key":"51","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1182\/blood-2013-06-511527","article-title":"Reciprocal leukemia-stroma VCAM-1\/VLA-4-dependent activation of NF-kappaB mediates chemoresistance","volume":"123","author":"Bueso-Ramos","year":"2014","journal-title":"Blood"},{"key":"52","first-page":"171","article-title":"The interplay between autophagy and ROS in tumorigenesis","volume":"2","author":"Karantza","year":"2012","journal-title":"Frontiers in oncology"},{"key":"53","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1182\/blood-2012-04-424630","article-title":"Role of the microenvironment in mantle cell lymphoma: IL-6 is an important survival factor for the tumor cells","volume":"120","author":"Yi","year":"2012","journal-title":"Blood"},{"key":"54","doi-asserted-by":"crossref","first-page":"e838","DOI":"10.1038\/cddis.2013.350","article-title":"Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment","volume":"4","author":"Pan","year":"2013","journal-title":"Cell death & disease"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.7320","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T16:47:47Z","timestamp":1600188467000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.7320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,11]]},"references-count":54,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,3,22]]}},"alternative-id":["7320","26885608"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.7320","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,11]]}}}